JPH07138152A - Cataplasm for medical use and cataplasm preparation - Google Patents

Cataplasm for medical use and cataplasm preparation

Info

Publication number
JPH07138152A
JPH07138152A JP28481293A JP28481293A JPH07138152A JP H07138152 A JPH07138152 A JP H07138152A JP 28481293 A JP28481293 A JP 28481293A JP 28481293 A JP28481293 A JP 28481293A JP H07138152 A JPH07138152 A JP H07138152A
Authority
JP
Japan
Prior art keywords
support
patch
backing material
skin
cataplasm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP28481293A
Other languages
Japanese (ja)
Inventor
Kensuke Matsuoka
賢介 松岡
Toshinobu Tsuda
敏亘 津田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Priority to JP28481293A priority Critical patent/JPH07138152A/en
Publication of JPH07138152A publication Critical patent/JPH07138152A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To provide a cataplasm for medical use compliant with the extension/ contraction movement of the skin at its applied site and reduced in physical skin irritancy or strained feel after applied, and to provide a cataplasm preparation capable of administering in vivo a percutaneously absorbable medicinal substance. CONSTITUTION:The objective cataplasm for medical use can be obtained by the following method: a stretchable substrate is fixed in a stretched state by laminating one side thereof with a backing material and the other side is provided with a tack agent layer; the stretched fixation of the substrate is made so as to be 3-20% in its shrinkage rate on peeling off the backing material. The other objective cataplasm preparation can be obtained by incorporating a percutaneously absorbable medicinal substance in the tack agent layer.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は皮膚面に貼付使用中にお
ける物理的な皮膚刺激性を低減することができる医療用
貼付剤および貼付製剤に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a medical patch and patch preparation which can reduce physical skin irritation during application to the skin surface.

【0002】[0002]

【従来の技術】従来から、医療用貼付剤としては各種ド
レッシングや手術用ドレープ、絆創膏など皮膚面に粘着
によって貼付するものが市販されている。また、粘着剤
中に薬物を含有させてなる貼付製剤としては、局所用薬
物であるサリチル酸メチルやサリチル酸グリコール、メ
ントールなどを含有させたハップ剤やプラスターなどが
市販されており、近年では全身用薬物を粘着剤中に含有
させて薬物を経皮吸収によって体内へ投与する貼付製剤
も各種開発されている。
2. Description of the Related Art Conventionally, as medical patches, various dressings, surgical drapes, adhesive plasters, etc. that are adhered to the skin surface by adhesion are commercially available. Further, as a patch preparation containing a drug in an adhesive, a topical drug such as methyl salicylate or glycol salicylate, a plaster or the like containing a menthol and the like is commercially available, and in recent years, a systemic drug Various patch preparations have been developed in which the drug is contained in an adhesive and the drug is administered into the body by transdermal absorption.

【0003】これらの医療用貼付剤や貼付製剤はいずれ
も粘着剤によって皮膚面に貼付、固定するものである
が、被着体である皮膚面は貼付中、常に伸縮運動を行っ
ている。特に、肘や膝などの関節部では屈曲させた際の
内側の皮膚は大きく収縮し、外側の皮膚は伸長してい
る。従って、このような動きをする皮膚面に上記貼付剤
や貼付製剤を貼付すると、貼付部位の皮膚面の伸縮運動
が阻害されて皮膚面につっぱり感などの違和感が生じる
ようになる。
All of these medical patches and patch preparations are stuck and fixed on the skin surface with an adhesive, but the skin surface, which is the adherend, is constantly expanding and contracting during sticking. In particular, at the joints such as elbows and knees, the inner skin when contracted is greatly contracted, and the outer skin is elongated. Therefore, when the patch or patch preparation is applied to the skin surface that moves in this way, the stretching motion of the skin surface at the application site is obstructed and the skin surface becomes uncomfortable such as a tightness.

【0004】また、皮膚面の伸縮運動は貼付部位にとど
まらず、その周囲の皮膚面も当然ながらその動きに追従
して伸縮運動するので、貼付部位周辺の皮膚にもつっぱ
り感が生じ、その結果、貼付部位の皮膚および貼付剤や
貼付製剤の周縁部に物理的な皮膚刺激が生じるようにな
る。
Further, since the expansion and contraction movement of the skin surface is not limited to the sticking site, and the skin surface around it also naturally expands and contracts in accordance with the movement, so that the skin around the sticking area feels a tactile sensation. , Physical skin irritation will occur on the skin at the site of application and the peripheral part of the patch or patch preparation.

【0005】上記実情から貼付部位が関節部などに限定
されない全身性薬物を含有する貼付製剤の場合には、で
きるだけ皮膚の伸縮運動が起こりにくい胸部や背部など
に貼付することが多いが、これらの貼付製剤は一般に長
時間にわたって貼付することが多いので、上記皮膚刺激
性の発現を抑制しがたいものである。
From the above facts, in the case of patch preparations containing systemic drugs whose application site is not limited to joints and the like, they are often applied to the chest or back, where skin stretching and contraction are less likely to occur. Since the patch preparation is generally applied over a long period of time, it is difficult to suppress the above skin irritation.

【0006】そこで、このような皮膚刺激性をできるだ
け低減する方法として伸縮性を有する支持体を用いる方
法があり、実用化されている。
Therefore, as a method for reducing such skin irritation as much as possible, there is a method using a stretchable support, which has been put to practical use.

【0007】上記伸縮性を有する支持体を用いた貼付剤
や貼付製剤は、通常、伸長させない状態で貼付するか、
伸長させた状態で貼付使用している。支持体を伸長させ
ない状態で貼付した場合、貼付部位の皮膚面が伸長する
場合には追従するが、収縮する場合、例えば関節部を屈
曲させた状態で貼付して関節部を伸ばした場合、貼付剤
は充分に収縮しきれずに違和感が生じる。一方、貼付剤
を伸長させた状態で貼付した場合にはこのような欠点は
ないものの、常に一定の伸長状態で貼付することが難し
く、皮膚刺激性が改善されたり改善されなかったりし
て、決して良好な方法とは云いがたいものである。
The patch or patch preparation using the above-mentioned stretchable support is usually applied in a non-stretchable state, or
It is attached and used in the expanded state. When affixed without stretching the support, it follows when the skin surface of the affixed site stretches, but when it contracts, for example, when affixed with the joint bent and the joint extended, The agent does not shrink sufficiently and an unpleasant sensation occurs. On the other hand, when the patch is applied in a stretched state, there is no such drawback, but it is difficult to stick in a constant stretched state at all times, and skin irritation is improved or not improved. It is hard to say that it is a good method.

【0008】[0008]

【発明が解決しようとする課題】従って、本発明の目的
は皮膚面に貼付使用中におけるつっぱり感などに伴う皮
膚刺激性を極力低減することができる医療用貼付剤およ
び貼付製剤を提供することにある。
SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a medical patch and patch preparation capable of reducing skin irritation associated with a tightness during use by applying it to the skin surface. is there.

【0009】[0009]

【課題を解決するための手段】そこで、本発明者らは上
記課題を解決するために鋭意研究を重ねた結果、支持体
として伸縮性を有する支持体を用いると共に、この支持
体を特定の比率に伸長させた状態で剥離可能な裏打ち材
にて固定すると、上記目的が達成できることを見い出
し、本発明を完成するに至った。
Therefore, as a result of intensive studies to solve the above problems, the inventors of the present invention have used a stretchable support as a support and have a specific ratio of this support. It was found that the above object can be achieved by fixing with a peelable backing material in a stretched state, and the present invention has been completed.

【0010】即ち、本発明は実質的に直交する2方向の
うち少なくとも1方向に伸縮性を有する支持体の片面に
剥離可能な裏打ち材を積層し、他面には粘着剤層が形成
されてなる貼付剤であって、上記支持体が伸長された状
態で裏打ち材によって固定されていると共に、裏打ち材
の剥離によって上記支持体が少なくとも1方向に3〜2
0%収縮することを特徴とする医療用貼付剤を提供する
ものである。
That is, according to the present invention, a peelable backing material is laminated on one surface of a support having elasticity in at least one of two directions substantially perpendicular to each other, and an adhesive layer is formed on the other surface. The adhesive patch according to claim 1, wherein the support is fixed in a stretched state by a backing material, and the support is peeled off in at least one direction by 3 to 2 in at least one direction.
The present invention provides a medical patch, which is characterized by shrinking by 0%.

【0011】さらに、本発明は上記医療用貼付剤におけ
る粘着剤層中に、経皮吸収性薬物を含有してなることを
特徴とするテープ製剤を提供するものである。
Furthermore, the present invention provides a tape preparation characterized in that a transdermal drug is contained in the pressure-sensitive adhesive layer in the above-mentioned medical patch.

【0012】本発明の医療用貼付剤および貼付製剤に用
いる支持体は、直交する2方向のち少なくとも1方向に
伸縮性を有するフィルム状、シート状であればその素材
には制限はなく、例えばポリウレタン(引張弾性率0.
6kg/mm2 )、ポリエチレン(同14kg/m
2 )、ポリプロピレン(同116kg/mm2 )、ポ
リ塩化ビニル(同0.4kg/mm2 )、エチレン−酢
酸ビニル共重合体(同2.5kg/mm2 )、グラフト
化エチレン−酢酸ビニル共重合体(同1kg/m
2 )、ポリブタジエン(同0.7kg/mm2 )など
を用いることができる。また、支持体の厚みは素材によ
って適宜変えることができるが、貼付時の違和感を少な
くするためには通常、5〜100μm、好ましくは10
〜30μm程度に設定する。
For the medical patch and patch preparation of the present invention
The support is in at least one direction out of the two orthogonal directions.
If it is a stretchable film or sheet, its material
There is no limit to the number, and for example, polyurethane (tensile elastic modulus of 0.
6 kg / mm2), Polyethylene (same 14kg / m
m2), Polypropylene (same as 116kg / mm2), Po
Polyvinyl chloride (same as 0.4 kg / mm2), Ethylene-vinegar
Vinyl acetate copolymer (2.5 kg / mm2), Graft
Ethylene-vinyl acetate copolymer (same 1 kg / m
m 2), Polybutadiene (same 0.7kg / mm2)Such
Can be used. The thickness of the support depends on the material.
Can be changed as appropriate, but there is less discomfort when attaching.
In order to reduce the thickness, it is usually 5 to 100 μm, preferably 10
It is set to about 30 μm.

【0013】また、本発明に用いる支持体の伸縮性の程
度は、貼付する皮膚面の動きに対する追従性の点から支
持体の引張弾性率(kg/mm2 )の値と、支持体の厚
み(μm)の3乗値との積が4800〜110000以
下とすることが好ましい。
The degree of stretchability of the support used in the present invention depends on the value of the tensile elastic modulus (kg / mm 2 ) of the support and the thickness of the support from the viewpoint of followability to the movement of the skin surface to be applied. The product of (μm) and the cube value is preferably 4800 to 110000 or less.

【0014】本発明において上記支持体の片面に積層す
る裏打ち材は、支持体を伸長状態で固定するためのもの
であり、柔軟性を必要とするものではないので厚みも適
宜設定すればよい。上記支持体への積層方法としては粘
・接着剤を介する積層や、加熱融着による積層、天然ゴ
ムバインダーを用いた積層、起毛クラフト紙による圧着
積層などの方法、インパルスシールや超音波シール、高
周波シールを用いる方法などがある。裏打ち材の素材と
しては合成紙、クラフト紙などの紙類、各種プラスチッ
クフィルムもしくはシート、各種発泡体シート、布類な
どを用いることができる。なお、このような裏打ち材は
本発明の医療用貼付剤もしくは貼付製剤を皮膚面に貼付
したのちに剥離除去できるようにするために、支持体へ
の接着力は後述する粘着剤層の皮膚接着力よりも小さく
なるように設定しておくことが必要である。
In the present invention, the backing material to be laminated on one surface of the support is for fixing the support in the stretched state and does not require flexibility, so the thickness may be set appropriately. As a method for laminating on the above support, laminating via viscous / adhesive, laminating by heat fusion, laminating with natural rubber binder, pressure laminating with raised kraft paper, impulse sealing or ultrasonic sealing, high frequency There is a method using a seal. As the material for the backing material, papers such as synthetic paper and kraft paper, various plastic films or sheets, various foam sheets, cloths and the like can be used. In addition, such a backing material has an adhesive force to a support, which is described below as skin adhesion of a pressure-sensitive adhesive layer, so that the medical patch or patch preparation of the present invention can be peeled and removed after being applied to the skin surface. It is necessary to set it so that it is smaller than the force.

【0015】上記のように支持体を伸長状態で裏打ち材
にて固定するには、例えばフラット法による同時2軸延
伸法を用いることができる。
To fix the support in the stretched state with the backing material as described above, for example, the simultaneous biaxial stretching method by the flat method can be used.

【0016】つまり、常法によって作成した伸縮性を有
する支持体をテンターに送り、支持体の両横端をテンタ
ーのクリップにて挟着、保持し、横方向に伸長すると同
時に一定のピッチで縦方向(長さ方向)にクリップ間隔
を拡大して伸長する。横方向に伸長させるのは縦方向に
伸長した際に横方向には収縮するので、これを防止する
ためであり、伸長前の横幅を維持できるようにクリップ
にて固定しておけば充分であり、積極的に伸長操作(拡
開操作)を行う必要はない。
That is, a stretchable support produced by a conventional method is sent to a tenter, and both lateral ends of the support are clamped and held by clips of the tenter, and are stretched in the lateral direction, and at the same time, they are vertically extended at a constant pitch. The clip interval is expanded and expanded in the direction (length direction). Extending in the horizontal direction is to prevent this because it contracts in the horizontal direction when it is extended in the vertical direction, so it is sufficient to fix it with clips so that the horizontal width before extension can be maintained. , It is not necessary to actively perform the extension operation (expansion operation).

【0017】次いで、支持体が伸長した状態で裏打ち材
を積層して伸長状態を維持した支持体を得ることができ
る。
Then, a backing material can be laminated in a stretched state of the support to obtain a support in which the stretched state is maintained.

【0018】本発明において上記支持体の他面、即ち裏
打ち材の積層面と反対面に形成される粘着剤層は、医療
用の粘着剤として皮膚に対する毒性を有しないものであ
ればアクリル系やゴム系、シリコーン系、ビニルエーテ
ル系などの粘着剤を用いることができるが、皮膚面への
優れた接着性の点からは疎水性高分子物質が好ましく、
特に安定した粘着特性の発揮や薬物を含有した場合の薬
物放出特性などの点からは(メタ)アクリル酸アルキル
エステルを主成分単量体として重合して得られるアクリ
ル系の粘着剤を用いることが好ましい。粘着剤層の厚み
は皮膚面の動きによっても剥脱しないようにするために
は10μm以上、剥離時の糊残り現象が生じないように
するためには40〜80μm程度の厚みで支持体面に形
成することが好ましい。なお、粘着剤層には粘着表面の
汚染を防止するために公知のセパレータを被覆積層して
おくことができる。
In the present invention, the pressure-sensitive adhesive layer formed on the other surface of the support, that is, the surface opposite to the laminated surface of the backing material, is an acrylic-based pressure-sensitive adhesive as long as it has no toxicity to the skin as a medical pressure-sensitive adhesive. A rubber-based, silicone-based, vinyl ether-based pressure-sensitive adhesive can be used, but a hydrophobic polymer substance is preferable from the viewpoint of excellent adhesion to the skin surface,
In terms of stable adhesive properties and drug release properties when a drug is contained, it is preferable to use an acrylic adhesive obtained by polymerizing (meth) acrylic acid alkyl ester as a main monomer. preferable. The pressure-sensitive adhesive layer is formed on the support surface with a thickness of 10 μm or more to prevent the adhesive layer from peeling off due to movement of the skin surface, and to have a thickness of about 40 to 80 μm to prevent the adhesive residue phenomenon during peeling. It is preferable. The pressure-sensitive adhesive layer may be coated and laminated with a known separator in order to prevent contamination of the pressure-sensitive surface.

【0019】本発明の貼付製剤における粘着剤層には経
皮吸収性の薬物が溶解状態もしくは分散状態で含有され
ている。含有させる薬物はその治療目的に応じて任意に
選択することができ、具体的にはコルチコステロイド
類、鎮痛消炎剤、催眠鎮静剤、精神安定剤、抗高血圧
剤、降圧利尿剤、抗生物質、麻酔剤、抗菌剤、抗真菌
剤、ビタミン剤、冠血管拡張剤、抗ヒスタミン剤、鎮咳
剤、性ホルモン、抗鬱剤、脳循環改善剤、制吐剤、抗腫
瘍剤、生体医薬などの種類の薬物であって、これらの薬
物は必要に応じて2種類以上併用することもできる。
The adhesive layer in the patch preparation of the present invention contains a transdermal drug in a dissolved or dispersed state. The drug to be contained can be arbitrarily selected according to the therapeutic purpose, and specifically, corticosteroids, analgesic and anti-inflammatory agents, hypnotics, tranquilizers, antihypertensive agents, antihypertensive diuretics, antibiotics, Anesthetics, antibacterial agents, antifungal agents, vitamins, coronary vasodilators, antihistamines, antitussives, sex hormones, antidepressants, cerebral circulation improvers, antiemetics, antitumor agents, biomedicals, etc. If necessary, two or more kinds of these drugs may be used in combination.

【0020】これらの薬物の含有量は薬物種や投与目的
に応じて適宜設定することができるが、通常、粘着剤層
中に1〜40重量%、好ましくは2〜30重量%程度含
有させる。含有量が1重量%に満たない場合は治療に有
効な量の薬物放出が期待できず、また、40重量%を超
えると治療効果に限界が生じると共に経済的に不利であ
る。
The content of these drugs can be appropriately set according to the type of drug and the purpose of administration, but it is usually contained in the pressure-sensitive adhesive layer in an amount of 1 to 40% by weight, preferably 2 to 30% by weight. When the content is less than 1% by weight, a therapeutically effective amount of the drug cannot be expected to be released, and when it exceeds 40% by weight, the therapeutic effect is limited and it is economically disadvantageous.

【0021】また、本発明においては上記粘着剤層に必
要に応じて、低級アルコールや、グリコール類、N−メ
チル−2−ピロリドン、ジメチルスルホキシド、ジメチ
ルアセトアミド、多価アルコール、セバケート類、液状
ゴム、粘着性付与樹脂の如き補助物質としての可塑剤や
経皮吸収促進剤や、シリカ粉末、タルク、チタン白、炭
酸カルシウム、セルロース系粉末、乳糖の如き各種充填
剤などを粘着特性を阻害しない範囲で含有させることが
できる。
In the present invention, if necessary, a lower alcohol, glycols, N-methyl-2-pyrrolidone, dimethylsulfoxide, dimethylacetamide, polyhydric alcohol, sebacates, liquid rubber, etc. may be added to the pressure-sensitive adhesive layer. Plasticizers and transdermal absorption promoters as auxiliary substances such as tackifying resins, various fillers such as silica powder, talc, titanium white, calcium carbonate, cellulosic powder, lactose, etc. within the range that does not hinder the adhesive properties. Can be included.

【0022】本発明の医療用貼付剤および貼付製剤は上
記構成からなるものであり、裏打ち材は支持体を伸長さ
せた状態で積層、固定することに特徴を有するものであ
る。本発明において支持体は裏打ち材を剥離除去した際
に、支持体が少なくとも1方向に3〜20%、好ましく
は3〜10%の範囲で収縮するように伸長させておくこ
とが必要である。つまり、3%に満たない場合には皮膚
の収縮に充分に追従できないために貼付剤に皺が入った
り、つっぱり感を与える原因となり、本発明の目的が充
分に達成できなくなる。また、20%を超えると貼付剤
に浮き現象を生じたり、皮膚に対して刺激を与える原因
となるのである。
The medical patch and patch preparation of the present invention have the above-mentioned constitution, and the backing material is characterized in that the support is laminated and fixed in a stretched state. In the present invention, the support needs to be stretched so that the support contracts in at least one direction in the range of 3 to 20%, preferably 3 to 10% when the backing material is removed. That is, when the amount is less than 3%, the shrinkage of the skin cannot be sufficiently followed, which causes wrinkles or a feeling of tightness in the patch, and the object of the present invention cannot be sufficiently achieved. On the other hand, if it exceeds 20%, the patch may cause a floating phenomenon or may cause irritation to the skin.

【0023】さらに、本発明の医療用貼付剤および貼付
製剤は、支持体の最大伸縮方向を長辺とする幅1cm、
長さ5cmの短冊状に裁断し、短辺を固定した状態で裏
打ち材を剥離した際、支持体の収縮応力は1〜300g
程度となる。この範囲の収縮応力を有することによっ
て、皮膚面に貼付した際に物理的な皮膚刺激を与えずに
優れた皮膚追従性を発揮するのである。
Furthermore, the medical patch and patch preparation of the present invention have a width of 1 cm with the longest side in the maximum stretching direction of the support,
When the backing material is peeled off with the short side fixed while being cut into a 5 cm long strip, the contraction stress of the support is 1 to 300 g.
It will be about. By having the contraction stress in this range, excellent skin followability is exhibited without giving physical skin irritation when applied to the skin surface.

【0024】以上のような本発明の医療用貼付剤および
貼付製剤を皮膚面に貼付する方法としては、まず粘着剤
層面を被着体である皮膚面に貼着し、そののち支持体の
片面に積層している裏打ち材を剥離除去するだけでよい
が、貼付に際して皮膚面は作為的に伸長や伸縮させない
状態であることが本発明の効果を最大限に発揮できるの
で好ましい。また、裏打ち材表面には支持体の伸縮方向
を矢印などの記号によって表記しておくと、貼付に際し
て皮膚面の伸縮方向に合わせて貼付できるので皮膚追従
性の点から好ましい。
As a method for applying the medical patch and patch preparation of the present invention as described above to the skin surface, first, the adhesive layer surface is applied to the skin surface which is the adherend, and then one surface of the support. It is only necessary to peel off and remove the backing material laminated on, but it is preferable that the skin surface is not artificially stretched or expanded during application because the effect of the present invention can be maximized. In addition, it is preferable that the direction of expansion and contraction of the support is described on the surface of the backing material by a symbol such as an arrow, because the adherence can be made in accordance with the direction of expansion and contraction of the skin surface when sticking, from the viewpoint of skin followability.

【0025】[0025]

【発明の効果】本発明の医療用貼付剤および貼付製剤は
以上のように、伸縮性を有する支持体を特定比率にて伸
長した状態で裏打ち材にて積層、固定しているので、こ
れを皮膚面に貼付したのち裏打ち材を剥離すると、皮膚
面の伸縮運動に追従できて物理的な皮膚刺激性を低減す
ることができる。特に、本発明のように一定の比率にて
伸長することによって、皮膚面の伸縮運動に追従できる
範囲が大きくなり、経皮吸収性薬物を含有させた貼付製
剤のように長時間の貼付が必要な場合において顕著にそ
の効果を発揮する。
As described above, the medical patch and patch preparation of the present invention are laminated and fixed with a backing material in a state where a stretchable support is stretched at a specific ratio. When the backing material is peeled off after being attached to the skin surface, it is possible to follow the expansion and contraction movement of the skin surface and reduce physical skin irritation. In particular, by stretching at a constant ratio as in the present invention, the range that can follow the expansion and contraction movement of the skin surface becomes large, and it is necessary to apply it for a long time like a patch preparation containing a transdermal drug. In that case, the effect is remarkably exhibited.

【0026】また、皮膚面の動きに対する追従性が向上
するので粘着剤自体の皮膚接着力を強くする必要がなく
なり、剥離除去時における痛みなどの刺激も低減するこ
とができるのである。
Further, since the followability to the movement of the skin surface is improved, it is not necessary to strengthen the skin adhesive force of the adhesive itself, and the irritation such as pain at the time of peeling and removing can be reduced.

【0027】[0027]

【実施例】以下に本発明の実施例を示し、さらに具体的
に説明する。なお、以下において部は重量部を意味す
る。
EXAMPLES Examples of the present invention will be shown below and will be described more specifically. In the following, parts mean parts by weight.

【0028】実施例1〜6 厚さ20μmのポリウレタンシートを支持体として、こ
の支持体を表1に示す伸長率で横方向に伸長しながら裏
打ち材としてのポリスチレンシート(厚さ0.25m
m)を加熱圧着して積層した。
Examples 1 to 6 A polyurethane sheet having a thickness of 20 μm was used as a support, and this support was stretched in the lateral direction at the elongation rate shown in Table 1 and a polystyrene sheet (0.25 m in thickness) as a backing material.
m) was thermocompression bonded and laminated.

【0029】粘着剤としてアクリル酸2−エチルヘキシ
ルエステル/アクリル酸(95部/5部)を共重合した
ものを用い、粘着剤溶液として表面にシリコーン処理を
施したセパレータに乾燥後の厚みが40μmとなるよう
に塗布、乾燥し、粘着剤層を形成した。
As a pressure-sensitive adhesive, a copolymer of acrylic acid 2-ethylhexyl ester / acrylic acid (95 parts / 5 parts) was used. As a pressure-sensitive adhesive solution, a separator whose surface was treated with silicone had a dry thickness of 40 μm. It was applied and dried to form an adhesive layer.

【0030】形成した粘着剤層を前記支持体の裏打ち材
積層面とは反対の面に転写形成して本発明の医療用貼付
剤を作製した。
The formed pressure-sensitive adhesive layer was transferred and formed on the surface of the support opposite to the surface on which the backing material was laminated to prepare a medical patch of the present invention.

【0031】実施例7 厚さ10μmのポリプロピレンシート(引張弾性率11
0kg/mm2 )を3%伸長させて裏打ち剤に積層した
以外は、実施例1と同様にして医療用貼付剤を作製し
た。
Example 7 Polypropylene sheet having a thickness of 10 μm (tensile modulus 11
A medical patch was produced in the same manner as in Example 1 except that 0 kg / mm 2 ) was stretched by 3% and laminated on a backing agent.

【0032】得られた医療用貼付剤から裏打ち材を剥離
した時の支持体の収縮率および収縮応力は表1に示す値
を示した。
The contraction rate and contraction stress of the support when the backing material was peeled from the obtained medical patch were the values shown in Table 1.

【0033】比較例1 上記実施例において支持体を伸長せずに裏打ち材を積層
した以外は、実施例と同様にして医療用貼付剤を作製し
た。支持体の伸長率、収縮率、収縮応力は表1に示す通
りである。
Comparative Example 1 A medical patch was prepared in the same manner as in Example 1 except that the backing material was laminated without stretching the support. The elongation rate, contraction rate, and contraction stress of the support are as shown in Table 1.

【0034】比較例2 上記実施例において支持体を30%伸長して裏打ち材を
積層した以外は、実施例と同様にして医療用貼付剤を作
製した。支持体の伸長率、収縮率、収縮応力は表1に示
す通りである。
Comparative Example 2 A medical patch was prepared in the same manner as in Example 1 except that the support was stretched 30% and a backing material was laminated in the above example. The elongation rate, contraction rate, and contraction stress of the support are as shown in Table 1.

【0035】比較例3 支持体として伸縮性を示さず、伸長性のみを示すポリテ
トラフルオロエチレンフィルム(日東電工株式会社製、
NTFフィルム、弾性を示さず))を用いた以外は、比
較例1と同様にして医療用貼付剤を作製した。支持体の
伸長率、収縮率、収縮応力は表1に示す通りである。
Comparative Example 3 A polytetrafluoroethylene film (manufactured by Nitto Denko Co., Ltd.) that does not exhibit stretchability but only stretchability as a support.
A medical patch was produced in the same manner as in Comparative Example 1 except that an NTF film, which did not exhibit elasticity)) was used. The elongation rate, contraction rate, and contraction stress of the support are as shown in Table 1.

【0036】比較例4 支持体として厚さ12μmのポリエチレンテレフタレー
トフィルム(引張弾性率200kg/mm2 )を用い、
裏打ち材を積層しなかった以外は、比較例1と同様にし
て医療用貼付剤を作製した。支持体の伸長率、収縮率、
収縮応力は表1に示す通りである。
Comparative Example 4 A polyethylene terephthalate film having a thickness of 12 μm (tensile elastic modulus of 200 kg / mm 2 ) was used as a support,
A medical patch was produced in the same manner as in Comparative Example 1 except that the backing material was not laminated. Elongation rate, contraction rate of the support,
The shrinkage stress is as shown in Table 1.

【0037】[0037]

【表1】 [Table 1]

【0038】実験例1 上記のようにして得られた各医療用貼付剤を5cm×5
cm角の大きさに裁断し、被験者の胸部皮膚面に貼付
し、裏打ち材を除去した(n=2)。24時間日常生活
を行ったのち、各貼付剤を除去して除去後の皮膚面を目
視判定して、皮膚刺激性および貼付中における貼付感を
調べた。結果を表2に示す
Experimental Example 1 5 cm × 5 of each medical patch obtained as described above
It was cut to a size of cm square, and attached to the skin surface of the chest of the subject, and the lining material was removed (n = 2). After daily living for 24 hours, each patch was removed, and the skin surface after removal was visually evaluated to examine the skin irritation and the feeling of sticking during application. The results are shown in Table 2.

【0039】実験例2 上記のようにして得られた各医療用貼付剤を2cm×2
cm角の大きさに裁断し、被験者の右上腕部の関節から
約5cm手首側に貼付剤の中心が位置するようにし、さ
らに関節と手首を結ぶ線と貼付剤の最も収縮する方向と
が一致するように貼付し、裏打ち材を除去した。貼付後
5分間静置し、そののち腕をゆっくりと3分間屈伸させ
た。屈伸中での貼付剤の浮き、貼付剤の皺、つっぱり
感、貼付感を調べた。結果を表2に示す。
Experimental Example 2 2 cm × 2 of each medical patch obtained as described above
Cut into cm-sized pieces so that the center of the patch is located approximately 5 cm from the joint of the subject's upper right arm on the wrist side, and the line connecting the joint and the wrist and the direction of most contraction of the patch match And the backing material was removed. After sticking, the plate was left standing for 5 minutes, and then the arm was flexed and extended slowly for 3 minutes. The floating of the patch during bending and stretching, the wrinkles of the patch, the feeling of tightness, and the feeling of application were examined. The results are shown in Table 2.

【0040】[0040]

【表2】 [Table 2]

【0041】表2の結果から明らかなように、本発明の
医療用貼付剤は貼付する皮膚面の動きに対する追従性に
優れて皮膚刺激性も少なく、貼付感が良好であることが
判る。なお、本発明の医療用貼付剤に経皮吸収性の薬物
を含有させて貼付製剤を作製したところ、皮膚追従性や
皮膚刺激性、貼付感などの結果は上記医療用貼付剤と大
差なく良好なものであった。
As is clear from the results shown in Table 2, the medical patch of the present invention has excellent followability to the movement of the skin surface to which it is applied, has less skin irritation, and has a good patch feeling. When a patch preparation was prepared by incorporating a transdermal drug into the medical patch of the present invention, the results such as skin followability, skin irritation, and feeling of sticking were substantially the same as those of the medical patch described above. It was something.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 実質的に直交する2方向のうち少なくと
も1方向に伸縮性を有する支持体の片面に剥離可能な裏
打ち材を積層し、他面には粘着剤層が形成されてなる貼
付剤であって、上記支持体が伸長された状態で裏打ち材
によって固定されていると共に、裏打ち材の剥離によっ
て上記支持体が少なくとも1方向に3〜20%収縮する
ことを特徴とする医療用貼付剤。
1. A patch comprising a support having elasticity in at least one of two directions substantially perpendicular to each other, a releasable backing material laminated on one surface, and an adhesive layer formed on the other surface. The medical patch, wherein the support is fixed in a stretched state by a backing material, and the support contracts 3 to 20% in at least one direction due to peeling of the backing material. .
【請求項2】 粘着剤層の皮膚接着力が、裏打ち材と支
持体との接着力よりも大きい請求項1記載の医療用貼付
剤。
2. The medical patch according to claim 1, wherein the adhesive force of the adhesive layer on the skin is greater than the adhesive force between the backing material and the support.
【請求項3】 請求項1記載の医療用貼付剤における粘
着剤層に経皮吸収性薬物を含有してなる貼付製剤。
3. A medicated patch according to claim 1, wherein the adhesive layer contains a percutaneously absorbable drug.
JP28481293A 1993-11-15 1993-11-15 Cataplasm for medical use and cataplasm preparation Pending JPH07138152A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28481293A JPH07138152A (en) 1993-11-15 1993-11-15 Cataplasm for medical use and cataplasm preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28481293A JPH07138152A (en) 1993-11-15 1993-11-15 Cataplasm for medical use and cataplasm preparation

Publications (1)

Publication Number Publication Date
JPH07138152A true JPH07138152A (en) 1995-05-30

Family

ID=17683335

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28481293A Pending JPH07138152A (en) 1993-11-15 1993-11-15 Cataplasm for medical use and cataplasm preparation

Country Status (1)

Country Link
JP (1) JPH07138152A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10101553A (en) * 1996-09-24 1998-04-21 Bando Chem Ind Ltd Substrate for percutaneously administrative medicine
US6262330B1 (en) 1998-12-02 2001-07-17 Nichiban Co., Ltd. Pressure sensitive adhesive tape for skin and base material therefor
JP2020169137A (en) * 2019-04-03 2020-10-15 凸版印刷株式会社 Patch support film, laminate, and patch
US11785714B2 (en) 2018-11-22 2023-10-10 Murata Manufacturing Co., Ltd. Extensible and contractible wiring board and method for manufacturing extensible and contractible wiring board

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10101553A (en) * 1996-09-24 1998-04-21 Bando Chem Ind Ltd Substrate for percutaneously administrative medicine
US6262330B1 (en) 1998-12-02 2001-07-17 Nichiban Co., Ltd. Pressure sensitive adhesive tape for skin and base material therefor
US11785714B2 (en) 2018-11-22 2023-10-10 Murata Manufacturing Co., Ltd. Extensible and contractible wiring board and method for manufacturing extensible and contractible wiring board
JP2020169137A (en) * 2019-04-03 2020-10-15 凸版印刷株式会社 Patch support film, laminate, and patch

Similar Documents

Publication Publication Date Title
US7063859B1 (en) Barrier film lined backing layer composition and method for topical administration of active agents
JP5285198B2 (en) Patch
KR100740056B1 (en) Stretchable patch
US20110208103A1 (en) Disposable medical article with multiple adhesives for skin attachment
JP2001517539A (en) Bandage
JPH09154933A (en) Medical adhesive tape and first-acid adhesive tape
ES2748243T3 (en) Overlap with improved compatibility and long adhesion time, and procedure for its production
WO2001093839A1 (en) Member for application of ointment and ointment patch employing the same
JP4799783B2 (en) Elastic patch
JPH037153A (en) Film layer covering apparatus
JPH07138152A (en) Cataplasm for medical use and cataplasm preparation
JP2000230157A (en) Stretchable adhesive tape or sheet
JP3171935B2 (en) Patch with excellent sticking properties
WO2009084611A1 (en) Antipruritic sheet
JP2000271204A (en) Adhesive product for medical use
CN111479545B (en) Adhesive elastic beautifying belt
JPH0698931A (en) Tacky adhesive sheet having good handling quality
JP2690112B2 (en) Medical patch
JP3207257B2 (en) Patch
JP2022543537A (en) Acrylic polymer and adhesive composition
JP2000175960A (en) Strap
JPS6075428A (en) Remedial adhesive tape or sheet
JPH11349476A (en) Medical pasting material
JP3308628B2 (en) Medical patch
JP2000256214A (en) Antiphlogistic-sedative plaster